Also available in Persian — نسخه فارسی ✈️ Telegram EN فا
ISNA is a semi-official Iranian news agency (Iranian Students News Agency). This is a translation of that outlet's own report; it is the outlet's account, not Artesh's finding. See what Iranian state media is saying today.
❓ Unknown

300 Million Dollars in Currency Expenditure for Plasma-Derived Products / Self-Sufficiency in the Plasma Industry on the Agenda

Sep 19, 2026 September 19, 2026 1 min read 📰 ISNA
📋 Key Takeaway

Iran's Food and Drug Organization highlights the significant annual cost of importing plasma-derived products, amounting to 300 million dollars. The emphasis on developing the domestic plasma industry aims to achieve self-sufficiency, which is crucial for the country's healthcare needs.

🔍 Quick Context Guide
💡 Bottom Line: Iran aims to cut down on costly imports by developing its plasma industry, which is vital for its healthcare system.

👥 Key Players

Iran's Food and Drug Organization MENTIONED
Regulatory body overseeing food and drug safety
"They play a crucial role in ensuring the quality and availability of medical products in Iran."
Deputy and Executive Assistant to the Head of the Food and Drug Organization MENTIONED
Official responsible for public health policy and drug regulation
"Their statements influence healthcare policy and funding priorities in Iran."

📰 What Happened

Iran's Food and Drug Organization reported an annual expenditure of approximately 300 million dollars on imported plasma-derived products. They emphasized the need to develop domestic production to achieve self-sufficiency in this critical healthcare sector.

  • 300 million dollars is spent annually on importing plasma-derived products like IVIG and albumin.
  • The development of the plasma industry is deemed essential for healthcare self-sufficiency.

💡 Why It Matters

🇮🇷 For Iran: Achieving self-sufficiency in plasma-derived products could reduce reliance on imports and improve healthcare access.
🌍 Regional: Strengthening domestic production may enhance Iran's regional influence in healthcare capabilities.
🌐 International: This move could signal Iran's intent to become more self-reliant amid ongoing sanctions and economic isolation.

📚 Background

Plasma-derived products are essential for treating various medical conditions, and reliance on imports can be risky, especially under sanctions. Developing domestic production is a strategic priority for Iran's healthcare system.

Sanctions on Iran's economy Iran's healthcare system and public health policies
📡 Source: STATE MEDIA
📊 Confidence: 70%
As a state-run organization, the Food and Drug Organization's reports may emphasize government achievements and downplay challenges.

The deputy and executive assistant to the head of the Food and Drug Organization pointed out the high currency expenditure for plasma-derived products such as IVIG, albumin, and coagulation factors, stating that approximately 300 million dollars is spent annually on the import of these products. Given their critical importance, the development of the plasma industry and the move towards self-sufficiency in this area is essential.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 85%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →